Safety and Efficacy of the BTL-703 Treatment for the Non-invasive Lipolysis

NCT03545360 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2018-06-04

No results posted yet for this study

Summary

The study will evaluate safety and efficacy of the BTL-703 device for the non-invasive lipolysis.

Conditions

Interventions

DEVICE

BTL-703 (Treatment group)

Treatment with BTL-703 device

Sponsors & Collaborators

  • BTL Industries Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2018-12-01
Completion
2019-01-01

Countries

  • Bulgaria

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03545360 on ClinicalTrials.gov